Adaptive Biotechnologies Corp. (ADPT)
16.24
-0.18
(-1.10%)
USD |
NASDAQ |
Dec 31, 16:00
16.42
+0.18
(+1.11%)
After-Hours: 07:17
Adaptive Biotechnologies Research and Development Expense (TTM): 85.20M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.097B |
| Zymeworks, Inc. | 142.83M |
| Cue Biopharma, Inc. | 28.14M |
| Recursion Pharmaceuticals, Inc. | 433.37M |
| Arcellx, Inc. | 168.16M |